In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...

DEEPER OUS is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland ...

The final results from the DETOUR2 study evaluated the durability of percutaneous transmural arterial bypass (PTAB) using the D ...

Two-year outcomes from the PROMISE II trial assessed transcatheter arterialization of the deep veins (TADV) using the LimFlow S ...

A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...

Two-year outcomes were reported from the CLOUT registry, which is a prospective, multicenter study evaluating patient ...

The Disrupt PAD BTK II study’s 30-day outcomes were revealed. The core lab–adjudicated, prospective, multicenter, s ...

The 2-year results from the LIFE-BTK randomized controlled trial highlighted the sustained benefits of the Esprit below-the-kne ...

The prospective, multicenter ROADSTER 3 postapproval trial is evaluating the safety and effectiveness of transcarotid artery re ...

The RESTORE ATK and RESTORE BTK trials assessed the laser- and optics-based Bolt peripheral intravascular lithotripsy (IVL) sys ...

The first clinical use of the Javelin peripheral intravascular lithotripsy (IVL) catheter (Shockwave Medical) for the treatment ...

The safety and effectiveness of the Neuroguard IEP (Contego Medical)—a three-in-one carotid stent system with integrated ...